Differences in Asthma-Related Outcomes by Anti-Il-5 Biologics, Omalizumab, and Dupilumab Based on Blood Eosinophil Counts.

Yuya Kimura,Maho Suzukawa,Norihiko Inoue,Shinobu Imai,Hiromasa Horiguchi,Manabu Akazawa,Hirotoshi Matsui

Asian Pacific journal of allergy and immunology（2024）

引用 0|浏览4

暂无评分

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要